MedTrace Logo

Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome

NCT01157312 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2010-07-19

No results posted yet for this study

Summary

The purpose of this study is to compare and determine the the efficacy of minimal stimulation and clomiphene citrate(CC) as the first-line treatment in infertile women with Polycystic Ovary Syndrome(PCOS).

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

clomiphene citrate +highly purified uFSH

DRUG

clomiphene citrate

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Hatem Abu Hashim, MD MRCOG · Mansoura University Hospital

  • Mohamed F Bazeed, MD · Mansoura University Hospital

  • Ibrahim Abd Elaal, MD · Mansoura University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01157312 on ClinicalTrials.gov